Clinical Research Directory
Browse clinical research sites, groups, and studies.
COVID-19 Pandemic Lockdown Effect in Adolescents and Young Adults With Type 1 Diabetes: Positive Results of an Unpreceded Challenge for Telemedicine and Patient Self-management
Sponsor: Centre Hospitalier Sud Francilien
Summary
Lockdown resulting from the COVID-19 pandemic was an unpreceded model of the impact of lifestyle on chronic diseases, especially for adolescents and young adults with type 1 diabetes (T1D) whose lifestyle is known to strongly impact disease management. The investigators aimed to assess changes in self-monitoring and glycemic control in this population before, during, and after the two-month French lockdown. Te investigators hypothesized an improvement in glucose control and glucose sensor usage. The protocol will include all patients with T1D from 13 to 25 years old using a flash glucose monitoring related to the LibreView cloud platform. The primary outcome, evolution of percentage of glucose time in range 70-180 mg/dL (TIR), and secondary outcomes (glucose management indicator GMI, time spent below range TBR, and sensor usage) will be analyzed with a linear mixed-effects regression model.
Official title: Observational Study of Glycemic Control and Self-management of Young People (Aged 13 to 25 Years ) With Type 1 Diabetes During COVID-19 Lockdown.
Key Details
Gender
All
Age Range
13 Years - 25 Years
Study Type
OBSERVATIONAL
Enrollment
77
Start Date
2021-01-15
Completion Date
2021-01-22
Last Updated
2026-05-22
Healthy Volunteers
No
Conditions
Interventions
glucose control and sensor usage
Data related to glucose control and sensor usage collected from the Libreview platform
Locations (1)
Centre Hospitalier Sud Francilien
Corbeil-Essonnes, France, France